Free radicals and antioxidants

Journal of Anaesthesiology Clinical Pharmacology

Volumn 19, Issue 1, 2003, Pages 15-32

  Arora, S ^a   Chopra, S C ^a   Gupta, C ^a  

^a DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIOXIDANT; ASCORBIC ACID; ASTAXANTHIN; CARBONATE DEHYDRATASE; CAROTENOID; CATALASE; CERULOPLASMIN; FERRITIN; FREE RADICAL; GLUCOSE; GLUTATHIONE PEROXIDASE; HEME OXYGENASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYPOXANTHINE; LACTOFERRIN; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; RETINOL; SUPEROXIDE; SUPEROXIDE DISMUTASE; TOXIN; TRANSFERRIN; UBIDECARENONE; URIC ACID; VITAMIN D; XANTHINE; XANTHINE DEHYDROGENASE; XANTHOPHYLL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; AIR POLLUTANT; ALCOHOLISM; ATHEROSCLEROSIS; CANCER; CELL DAMAGE; CHEMICAL REACTION; CIGARETTE SMOKING; DIABETES MELLITUS; DRUG METABOLISM; ELECTRON TRANSPORT; ENZYME ACTIVITY; EXERCISE; HEART FAILURE; HYPERTENSION; INFLAMMATORY DISEASE; INTENSIVE CARE; IONIZING RADIATION; ISCHEMIA; LIPID OXIDATION; LIPID PEROXIDATION; MITOCHONDRIAL ENERGY TRANSFER; NEUROLOGIC DISEASE; OXIDATION; OXIDATIVE STRESS; PHAGOCYTOSIS; PURINE METABOLISM; REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS; TRANSPLANTATION;

EID: 15244363189     PISSN: 09709185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Sen C.K. Oxygen toxicity and antioxidants: State of the art. Indian J Physiol Pharmacol 1995, 39(3): 177-96.
2. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994; 344: 721-24.
3. Antioxidants. http://www.celletch.com © 2002 Cell Tech.
4. Halliwell B, Gutteridge JMC. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet 1984; 1: 1396-97.
5. Yu BP. Cellular defenses against damage from Reactive Oxygen species. Physiol Rev 1994; 74: 139-62.
6. Hemnani T, Parihar MS. Reactive Oxygen species and oxidative DNA damage. Indian J Physiol Pharmacol 1998; 42(4): 440-52.
7. Southern PA, Powis G. Free radicals in medicine. I - Chemical nature and biologic reactions. Mayo Clin Proc 1988; 63: 381-89.
8. Fridovich I. The biology of oxygen radicals. Science Wash DC. 1978; 201: 875-80.
9. Esterbauer, Koller HE, Slee RG et al. Possible involvement of the lipid -peroxidation product 4-hydroxynoneal in the formation of fluorescent chromolipids. Biochem J 1986; 239: 405-09.
10. Pryor WA. Free radicals in autoxidation and in aging. In: Armstrong D, Sohal RS, Culter RG et al, eds. Free Radicals in Molecular Biology, Aging and Disease. New York: Raven, 1984; 13-42.
11. McCord JM, Fridovich I. The reduction of cytochrome C by milk xanthine oxidase. J Biol Chem 1968; 243: 5753-60.
12. Southern PA, Powis G. Free radicals in medicine II-Involvement in human disease. Mayo Clin Proc 1988; 63: 390-408.
13. Tyler DD. Polarographic assay and intracellular distribution of superoxide dismutase in rat liver. Biochem J 1975; 147: 493-504.
14. Turens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitrochondria. Biochem J 1980; 191: 421-27.
15. McCord JM, Fridovich I. The utility of superoxide dismutase in studying free radical reactions. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J Biol Chem 1969; 244: 6056-63.
16. Hellsten Y. The role of Xanthine Oxidase in exercise. In: Sen CK, Packer L, Hanninen O, eds. Exercise and oxygen toxicity. Amsterdam: Elesevier Science Publishers B.V., 1994; 221-34.
17. Granger DN, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterol 1981; 81: 22-24.
18. Maxwell SRJ. Prospects for the use of antioxidant therapies. Drugs 1995; 49(3): 345-67.
19. Girroti AW. Lipid hydroperoxide generation, turnover and effector action in biological systems. J Lipid Res 1998; 39: 1529-42
20. Esterbauer H. Aldehyde products of lipid peroxidation. In: McBrien DCH, Slater TF, eds. Free radicals, lipid peroxidation and cancer. London: Academic Press, 1982; 101-28.
21. Beckman JS, Crow JP. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans 1993; 21: 330-34.
22. Nitric oxide. In: Rang HP, Dale MM, Ritter JM, eds. Pharmacology. Edinburgh: Churchill Livingstone, 2000; 188-97.
23. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-09.
24. http://www.dietsearch.com/health/tobacco.html
25. http://intelegen.com/nutrients/antioxidants_weapon_against_smoking_1.htm
26. Duthie GG, Arthur JR. Cigarette smoking as an inducer of oxidative stress. In: Sen CK, Packer L, Hannine O, eds. Exercise and oxygen toxicity - injury by oxidative stress. Semin Liver Dis 1990; 10: 285-92.
27. Sulochana KN, Punitham R, Ramakrishnan S. Effect of cigarette smoking on cataract: Antioxidant enzymes and constituent minerals in the lens and blood of humans. Indian J Pharmacol 2002; 34: 428-31.
28. 2+ and membrane disintegration following exposure of myogenic cells to oxidative stress. XXXII Congress of the International Union of Physiological Sciences, Glasgow, Abstract book 284.5/P (Wednesday) 1993; 214.
29. Drug dependence and drug abuse. In: Rang HP; Dale MM, Ritter JM, eds. Pharmacology. Edinburgh: Churchill Livingstone, 2000; 614-33.
30. Griffiths HR, Unsworth J, Blake DR et al. Free Radicals in Chemistry, Pathology and Medicine. London: Richelieu, 1988; 439-54.
31. Hochstein P, Ernster L. ADP-activated lipid peroxidation coupled on TPNH oxidase system of microsomes. Biochem Biophys Res Commun 1963; 12: 388-94.
32. Hegner D. Age-dependence of molecular and functional changes in biological membrane properties. Mech Ageing Dev 1980; 14: 101-18.
33. Weddle CC, Hornbrook ET, McCay PB. Lipid peroxidation and alteration of membrane lipids in isolated hepatocytes exposed to carbon tetrachloride. J Biol Chem 1976; 251: 4973-78.
34. 2: modulation by dietary restriction. Mech Ageing Dev 1992; 65: 17-33.
35. Esterbauer H, Zollner H, Schaur RJ. Aldehydes formed by lipid peroxidation: mechanisms of formation, occurrence, and determination. In: Pelfrey CV, Raton B, eds. Membrane lipid oxidation. FL: CRC, 1990; 240-68.
36. Esterbaver H, Jurgons G, Quehenberger et al antoxidation of human low density lipoprotein loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes J lipid Res. 1987; 28: 495-509
37. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
38. Haberland M, Fong D, Cheng L. Malonclialdehydealtered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science Wash DC 1988; 241: 215-18.
39. Hagihara M, Nishigaki I, Maseki M et al. Age dependent changes in lipid peroxide levels in the lipoprotein fractions of human serum. J Gerontol 1984; 39: 269-72.
40. th ed. Noida: Thomson Press (1) ltd. 1999; 1-31.
41. Fraga CG, Shigenaga MK, Park JW et al. Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 1990, 87: 4533-37.
42. Backer JM, Weinstein B. Mitochondral DNA is a major cellular target for dihydrodiol-epoxide derivative of benzo(a)pyrene. Science Wash DC 1980; 209: 297-99.
43. Niranjan BG, Bhat NK, Avadhai NG. Preferential attack of mitochondrial DNA by aflatoxin BI during hepatocarcinogenesis. Science Wash DC 1982; 215: 73-75.
44. Saul R, Gee D, Ames BN. Free radicals, DNA damage and aging In: Warner HR, Butter RN, Sprott RL et al, eds. Modern biological theories of aging. New York: Raven, 1987; 113-29.
45. Dizdaroglu M. Formation of an 8-hydroxyguanine moiety in deoxyribonucleic acid on gamma irradiation in aqueous solution. Biochem 1985; 24: 4476-81.
46. Cutler RG. Antioxidant and longevity. In: Armstrong D, Sohal RS, Cutler RG, eds. Free Radicals in Molecular Biology, Aging and disease. New York: Raven, 1984; 235-66
47. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989; 140: 531-54.
48. Rice-Evans CA, Diplock AT. Current status of antioxidant therapy. Free Radic Biol Med 1993; 15: 77-96.
49. Meister A. Selective modification of glutathione metabolism. Science 1983; 220: 472-77.
50. Meister A. Metabolism and function of glutathione: In: Dolphin D, Peulson R, Avramovic O, eds. Glutathione-Chemical, biochemical and medical aspects. Vol 3, Part A. New York: John Wiley and sons, 1989; 367-89.
51. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.
52. Sen CK, Rahkila P, Hanninen O. Glutathione metabolism in skeletal muscle derived cells of the L6 line. Acta Physiol Scand 1993; 148: 21-26.
53. nd ed. Oxford: Calendron press, 1989.
54. Crichton RP. Ferritin. Struct Bonding 1973; 17: 67-134.
55. Modell B, Letsky EA, Flynn DM et al. Survival and desferrioxamine in thalassemia major. Br Med J 1982; 284: 1081-84.
56. Steinberg D, Parthasarthy S, Carew TE et al. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24.
57. Burton GW, Ingold KU. b-carotene is an unusual type of lipid antioxidant. Science Wash DC 1984; 224: 569-73.
58. Ji LL, Stratman FW, Lardy HA. Antioxidant enzyme systems in rat liver and skeletal muscle. Influences of selenium deficiency, chronic training, and acute exercise. Arch Biochem Biophys 1988; 263: 150-60.
59. Woffenbultel BHR, Graal MB. New treatments for patients with Type 2 Diabetes Mellitus. JAMA-India 1997; 21(6): 33-39.
60. Sen CK, Packer L, Hanninen O, eds. Exercise and oxygen toxicity. Amsterdam, Elsevier Science publisher B.V., 1994; 536.
61. Robertson JD, Maugham RJ, Duthie GG et al. Increased blood antioxidant systems of runners in response to training load. Clin Sci 1991; 80: 611-18.
62. Maxwell SRJ, Jakeman P, Thomason H et al. Changes in plasma antioxidant status during eccentric exercise and the effect of vitamin supplementation. Free Radic Res Common 1993; 19: 191-202.
63. Aruoma OI, Wasil M, Halliwell B et al. The scavenging of oxidants by sulphasalazine and its metabolities. Biochem Pharmacol 1987; 36: 3739-42.
64. Sen CK, Marin E, Eretzschmar M et al. Skeletal muscle and liver glutathione homeostasis in response to training, exercise and immobilization. J Appl Physiol 1992; 73: 1265-72.
65. Sen CK Rankiren TT, Vaisanen SV et al. Oxrdative stress after human exercise: effect of N-acetyl cysteine supplementation. J Appl Physiol 1994; 76: 2570-77.
66. Oberley LW, Oberley TD. Free radicals cancer and ageing. In: Johnson JE, Walford R, Harmon D et al, eds. Free radical ageing and degenerative diseases. New York: Liss, 1986; 325-71.
67. Orr WC, Sohal RS. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 1994; 263: 1128-30.
68. Steinbrecher UP, Parthasarathy S, Leake DS et al. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984; 81: 3883-87.
69. Steinbercher UP, Zhang H, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med 1990; 9: 155-68.
70. Jurgens G, Hoff HF, Chisolin GM et al. Modification of human serum low density lipoprotein by oxidation - characterization and pathophysiologic implications. Chem Phys Lipids 1987; 45: 315-36.
71. Diaz MN, Frei B, Vita J et al. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337(6) 408-16.
72. Rimm EB, stamp for MJ, Ascherio A et all Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328:1450-56
73. Stamfer MJ, Hennekens CH, Manson JE et al. Vitamin E consumption and the risk of coronary heart disease in women N Engl J Med 1993; 328:1446-49.
74. Luc G, Fruchart JC. Oxidation of lipoproteins and atherosclerosis. AM J Clin Nutr 1991; 53(Suppl): 206S-209S.
75. Parthasarathy S, Young SG, Witztum JL et al. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 1986; 77: 641-44.
76. Hertog MGL, Feskens EJM, Hollman PCH et al Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly study. Lancet 1993; 342: 1007-11.
77. ISIS-3 (third International Study of Infarct Survival) collaborative group. A randomised comparison of Streptokinase vs plasminogen activator vs antistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992; 339: 753-70.
78. McCord JM. Oxygen-derived free radicals in post-ischaemic tissue injury. N Engl J Med 1985; 312: 159-63.
79. Davies SW, Randajayalan K, Wickens DG et al. Lipid peroxidation associated with successful thrombolysis. Lancet 1990; 335: 741-43.
80. Coghlan JG, Flitter WD, Holley AE et al. Detection of free radicals and cholesterol hydroperoxides from the coronary sinus of man during percutaneous transluminal coronary angioplasty. Free Radic Res Commun 1991; 14: 409-17.
81. Regnstrom J, Nilsson J, Tornvall P et al. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992; 339: 1183-86.
82. Riemersma RA, Wood DA, MacIntyre CC et al. Risk of angina pectoris and plasma concentrations of vitamins A, C, E and carotene. Lancet 1991; 337: 1-5.
83. Fellstrom BC, Larrson E. Pathogenesis and treatment perspectives of chronic graft rejection. Immunol Rev 1993; 134: 83-98.
84. Land W, Schneeberger H, Schleinbner S et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211-17.
85. Currin RT, Toole JG, Thurman RG et al. Evidence that carolina rinse solution protects sinusoidal endothelial cells against reperfusion injury after cold ischaemic storage of rat liver. Transplantation 1990; 50: 1076-78.
86. Slakey DP, Roza AM, Pieper GM et al. Delayed cardiac allograft rejection due to combined cyclosporine and antioxidant therapy. Transplantation 1993; 56: 1305-09.
87. Oberley LW. Free radicals and Diabetes. Free Radic Biol Med 1988; 5: 113-24.
88. Nishigaki I, Hagihara M, Tsunekawa H et al. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 1978; 25: 373-78.
89. Barnett AH. Pathogenesis of diabetic microangiopathy: an overview. Am J Med 1991; 90 (Suppl) 6A: 67-73.
90. Reiser K. Nonenzymatic glycation of collagen in aging and diabetes. Proc Soc Exp Biol Med 1991; 37: 17-29.
91. Ohno II, Suzuki K, Fujii J et al. Superoxide dismutases in exercise and disease. In: Sen CK, Packer L, Hanninen O, eds. Exercise and oxygen toxicity. Amsterdam: Elsevier Science Publishers B.V., 1994; 127-62.
92. Hunt SV, Dean RP, Wolff SP. Hydroxyl radical production and auto-oxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging. Biochem J 1988; 256: 205-15.
93. Ceriello A, Giugliano D, Quatraro A et al. A preliminary note on inhibiting effect of alpha-tocopherol (vitamin E) on protein glycation. Diabet Metab 1988; 14: 40-42.
94. Ceriello A, Giugliano D, Quatraro A et al. Vitamin E reduction of protein glycosylation in diabetes: new prospects for prevention of diabetic complications. Diabetes Care 1991; 14: 68-72.
95. Ceriello A, Quatraro A, Giugliano D. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med 1992; 9: 297-99.
96. Babior BM. Oxygen dependent microbial killing by phagocytes. N Engl J Med 1978; 298: 659-68.
97. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989; 320: 365-76.
98. Blemond P, Van Eljk HG, Swaak AJG et al. Iron mobilisation from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes: possible mechanism in inflammatory diseases. J Clin Inves 1984; 73: 1576-79.
99. Winrow VR, Winyard PG, Morris CJ et al. Free radicals in inflammation: secondary messengers and mediators of tissue destruction. Br Med Bull 1993; 49: 506-22.
100. Edmonds SE, Blake DR. Hypoxia, oxidative stress and exercise in rheumatoid arthritis. In: Sen CK, Packer L, Hanninen O, eds. Exercise and oxygen toxicity. Amsterdam: Elsevier Science Publishers B.V., 1994; 221-34.
101. Schoenberg MH, Buchler M, Beger HG. The role of oxygen radicals in experimental acute pancreatitis. Free Radic Biol Med 1992; 12: 515-22.
102. Uden S, Bilton D, Nathan L et al. Antioxidant therapy for recurrent pancreatitis: placebo controlled trial. Aliment Pharmacol Ther 1990; 4: 357-71.
103. Swartz HM. Electron spin resonance studies of carcinogenesis. In: Klein G, Weinhouse S, eds. Advances in cancer research. New York: Acadamic Press. 1972; 227-52.
104. Thornalley PJ, Bannister JV. The spin trapping of superoxide radicals. In: Greenwald RA, eds. Handbook of methods for oxygen radical research. Boca Raton, FL: CRC, 1985; 133-36.
105. Srinivas L, Shalini VK. DNA damage by smoke: protection by tumeric and other inhibitors of ROS. Free Radic Biol Med 1991; 11: 277-83.
106. Pacht ER, Davis WB. Failure of high dose vitamin E to correct caeruloplasmin ferroxidase deficiency in cigarette smokers. Am Rev Resp Dis 1990; 42: 1063-67.
107. Bulpitt CJ. Vitamin C and blood pressure. J Hypertens 1990; 8: 1071-75.
108. Ceriello A, Giugliano D, Quatraro A et al. Antioxidants show an antihypertensive effect in diabetic and hypertensive subjects. Clin Sci 1991; 81: 739-42.
109. Standaert DG, Young AB. Treatment of central nervous system degenerative disorders. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill. 2001; 549-68.
110. Hall ED, Braughler JM. Central nervous system trauma and stroke. Free Radic Biol Med 1989; 6: 303-13.
111. Roederer M, Ela SW, Staal FJT et al. N-acetyl cysteine: a new approach to anti-HIV Therapy. AIDS Res Hum Retrov 1992; 8: 209-17.